TheEdgeResearch
Home / Stocks / HMPQ

HempAmericana, Inc (HMPQ)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$291,753
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.82
52-Wk Range
0.000001-0.0001
CEO
Salvador Rosillo
Country
US
Currency
USD

HempAmericana, Inc operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $291,753. On trailing twelve-month figures it carries a trailing P/E of -0.50, a net margin of -7074.2%. Its beta of -0.82 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.50
Price / Sales
37.44
Price / Book
-0.25
EV / EBITDA
-0.91
Gross margin
100.0%
Operating margin
-6010.0%
Net margin
-7074.2%
Return on equity
Debt / equity
-0.02
Current ratio
0.10
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2015-02-25
Headquarters
New York City, NY, US
About HempAmericana, Inc

Operating within the United States, HempAmericana, Inc. is dedicated to the research, development, and sale of various products crafted from industrial hemp. The company's diverse offerings include hemp-infused concrete, textile bags, seeds intended for consumption, apparel, and rolling papers. Established in 2014, the firm maintains its headquarters in New York, New York.

Comparable companies

HempAmericana, Inc is most often compared with the following Healthcare names:

AREVFCWWBFFFNTFGBHPFGRVEINQDINSOPZOORLBDVIVXF
More research on HMPQ
HMPQ technical analysis HMPQ TheEdge Score Compare against peers
Open full interactive analysis & DCF →